Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Raw_Blitzon Jan 09, 2019 6:54am
157 Views
Post# 29204440

Research on Cannabinoids Over the Decades and What’s to Come

Research on Cannabinoids Over the Decades and What’s to Come(spoiler: KALY get's quoted in this video)

In the 1960's, doctors started to test certain CBD compounds on animals with Epilepsy, and found out it doesn't only stop epilepsy attacks, but the treatment worked better than they expected. Clinical Trials were made on Humans and the results were mind-blowing.

But, at that time, the medicinal world refused to do more research about all of this. (Why?)

50 years later, we are now exploring CBD more than ever and are shocked by the fact that this Cannabinoid doesn't only cure a lot of diseases, it also helps with a lot of health problems people have these days such as chronic pain, sleep problems, the list goes on and on.

This video shows you what kind of treatments are being created TODAY to help those in need!

https://m.youtube.com/watch?v=4-KQh0VrYyw&feature=youtu.be

One of the companies he names is Kalytera, which had created a drug to cure people with GHVD!

CBD is the future! And the treatments they are creating will change the medicinal world!

Bullboard Posts